Pazopanib, another anti-angiogenesis drug, has shown positive results in Phase II trials for advanced kidney cancer.
For more information about pazopanib, see:
http://www.medicalnewstoday.com/articles/73025.php
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.